The clinical utility of CA125/MUC16 in pancreatic cancer: A consensus of diagnostic, prognostic and predictive updates by the Chinese Study Group for Pancreatic Cancer (CSPAC).
Liu L, Xiang J, Chen R, Fu D, Hong D, Hao J, Li Y, Li J, Li S, Mou Y, Mai G, Ni Q, Peng L, Qin R, Qian H, Shao C, Sun B, Sun Y, Tao M, Tian B, Wang H, Wang J, Wang L, Wang W, Wang W, Zhang J, Zhao G, Zhou J, Yu X; Chinese Study Group for Pancreatic Cancer (CSPAC).
Liu L, et al. Among authors: wang h, wang w, wang l, wang j.
Int J Oncol. 2016 Mar;48(3):900-7. doi: 10.3892/ijo.2015.3316. Epub 2015 Dec 30.
Int J Oncol. 2016.
PMID: 26718269